WO2023021472 - A PHARMACEUTICAL PLATFORM TECHNOLOGY FOR DRUG DISCOVERY AND CONSUMER HEALTH PRODUCT DEVELOPMENT
National phase entry:
Publication Number
WO/2023/021472
Publication Date
23.02.2023
International Application No.
PCT/IB2022/057780
International Filing Date
19.08.2022
Title **
[English]
A PHARMACEUTICAL PLATFORM TECHNOLOGY FOR DRUG DISCOVERY AND CONSUMER HEALTH PRODUCT DEVELOPMENT
[French]
TECHNOLOGIE DE PLATEFORME PHARMACEUTIQUE POUR LA DÉCOUVERTE DE MÉDICAMENTS ET LE DÉVELOPPEMENT DE PRODUITS DE SANTÉ DE CONSOMMATEURS
Applicants **
TAM, Yun Kau
1059 Tony Road
Edmonton, Alberta T6R 3A5, CA
SINOVEDA CANADA INC.
4294 91A Street
Edmonton, Alberta T6E 5V2, CA
Inventors
TSENG, Chih-Yuan
11-287 Macewan RD SW
Edmonton, Alberta T6W 1T4, CA
BJORNDAHL, Trent
15305 74 Avenue
Edmonton, Alberta T5R 2Y2, CA
Priority Data
63/234,910
19.08.2021
US
63/234,917
19.08.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
CIPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1461 | |
| EPO | Filing, Examination | 8032 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 5110 |
Total: 15801 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
In one embodiment, the present invention describes a method for identifying an optimized natural medicine containing defined doses of active and contributing ingredients. In one embodiment, the method disclosed in the present invention develops compositions comprising cannabinoids for the treatment of hepatocellular carcinoma.[French]
Dans un mode de réalisation, la présente invention concerne un procédé d'identification d'un médicament naturel optimisé contenant des doses définies de principes actifs et de contribution. Dans un mode de réalisation, le procédé décrit dans la présente invention développe des compositions comprenant des cannabinoïdes pour le traitement du carcinome hépatocellulaire.